These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 7793078)

  • 1. CTL escape viral variants. I. Generation and molecular characterization.
    Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB
    Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTL escape viral variants. II. Biologic activity in vivo.
    Lewicki HA; Von Herrath MG; Evans CF; Whitton JL; Oldstone MB
    Virology; 1995 Aug; 211(2):443-50. PubMed ID: 7645248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
    Hudrisier D; Oldstone MB; Gairin JE
    Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection.
    Oldstone MB; Lewicki H; Borrow P; Hudrisier D; Gairin JE
    J Virol; 1995 Dec; 69(12):7423-9. PubMed ID: 7494247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA; Ahmed R; Oldstone MB
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
    Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
    van der Most RG; Sette A; Oseroff C; Alexander J; Murali-Krishna K; Lau LL; Southwood S; Sidney J; Chesnut RW; Matloubian M; Ahmed R
    J Immunol; 1996 Dec; 157(12):5543-54. PubMed ID: 8955205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential usage of V alpha 4 and V beta 10 T cell receptor genes by lymphocytic choriomeningitis virus glycoprotein-specific H-2Db-restricted cytotoxic T cells.
    Aebischer T; Oehen S; Hengartner H
    Eur J Immunol; 1990 Mar; 20(3):523-31. PubMed ID: 2138558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptides control the gain and loss of allele specificity by mutated MHC class I molecules.
    Hengel H; Burke K; Kyburz D; Zinkernagel RM; Koszinowski UH
    J Immunol; 1995 May; 154(9):4557-64. PubMed ID: 7722309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity.
    Alexander-Miller MA; Burke K; Koszinowski UH; Hansen TH; Connolly JM
    J Immunol; 1993 Jul; 151(1):1-10. PubMed ID: 8392095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of point mutations in the native simian virus 40 tumor antigen, and in synthetic peptides corresponding to the H-2Db-restricted epitopes, on antigen presentation and recognition by cytotoxic T lymphocyte clones.
    Deckhut AM; Tevethia SS
    J Immunol; 1992 May; 148(10):3012-20. PubMed ID: 1374447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
    Browning MJ; Huang AS; Reiss CS
    J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes.
    Gairin JE; Mazarguil H; Hudrisier D; Oldstone MB
    J Virol; 1995 Apr; 69(4):2297-305. PubMed ID: 7533855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competition between unrelated peptides recognized by H-2-Kd restricted T cells.
    Pala P; Bodmer HC; Pemberton RM; Cerottini JC; Maryanski JL; Askonas BA
    J Immunol; 1988 Oct; 141(7):2289-94. PubMed ID: 2459204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection.
    Von Herrath MG; Coon B; Oldstone MB
    Virology; 1997 Mar; 229(2):349-59. PubMed ID: 9126248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes.
    Bachmann MF; Lutz MB; Layton GT; Harris SJ; Fehr T; Rescigno M; Ricciardi-Castagnoli P
    Eur J Immunol; 1996 Nov; 26(11):2595-600. PubMed ID: 8921944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo.
    Kyburz D; Speiser DE; Aebischer T; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Jun; 150(11):5051-8. PubMed ID: 7684417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
    Uger RA; Barber BH
    J Immunol; 1998 Feb; 160(4):1598-605. PubMed ID: 9469415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.